Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

As GLP-1 pills for weight loss enter the U.S. market, some pharmaceutical companies are testing the possibility of a gene therapy to stimulate GLP-1 production, The Washington Post reported Jan. 24.

Real-world analyses suggest link to reduced steroid use, fewer hospital stays, lower morta ...

US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that may mimic GLP-1 drugs for years after ...

Sally Lyons Wyatt, from Data analytics company Circana, says GLP-1 potential users are only three percent more likely to buy ...

LIR Life Sciences is a leader in the dvancement of novel, needle-free drug delivery platforms for obesity treatment across ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...

The use of GLP-1 receptor antagonist therapy has led to a greater reduction in colorectal cancer incidence than has been ...

ResMed is betting big on artificial intelligence (AI) to boost CPAP adherence. At the recent J.P. Morgan Healthcare Conference, CEO Mick Farrell said the company’s first AI-enabled medical device, Sma ...

Gene therapy for weight loss is being explored as a potential game-changer, with therapy aiming to program the body to ...

The GLP-1 moment signals how quickly a high-demand therapy can upend established care patterns—and how similar innovations may emerge in the years ahead.